Document Detail


Asymptomatic endometrial thickening.
MedLine Citation:
PMID:  21176311     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To formulate clinical recommendations for the assessment of endometrial thickening when it is found on ultrasound in a postmenopausal patient without bleeding.
OUTCOMES: Ensure that women with asymptomatic thickening and endometrial polyps found on ultrasound are managed appropriately.
EVIDENCE: Published literature was retrieved through searches of English language articles from the EMBASE, Cochrane, and PubMed databases for relevant peer-reviewed articles dating from 1970 to 2009, using appropriate controlled vocabulary (e.g., "asymptomatic endometrial thickness," "endometrial cancer," "postmenopausal bleeding," "transvaginal ultrasonography," "endometrial biopsy" and "endometrial polyp"). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. Searches were updated on a regular basis and incorporated in the guideline to April 2010. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.
VALUES: The level of evidence was determined according to the criteria established by the Canadian Task Force on Preventative Health Care (Table). Recommendations are ranked according to this method.
BENEFITS, HARMS, AND COSTS: It is anticipated that the adoption of these recommendations would save postmenopausal women unnecessary anxiety, pain, and risk of procedural complication. It is also expected to decrease the cost to the health system by eliminating unnecessary interventions.
Authors:
Wendy Wolfman; Nicholas Leyland; Mark Heywood; Sukhbir S Singh; David Allan Rittenberg; Renée Soucy; Catherine Allaire; Alaa Awadalla; Carolyn Best; Sheila Dunn; Nathalie Leroux; Frank Potestio; Vyta Senikas; Sarah Wallace; Rebecca Menzies; Society of Obstetricians and Gynaecologists of Canada
Publication Detail:
Type:  Journal Article; Practice Guideline    
Journal Detail:
Title:  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC     Volume:  32     ISSN:  1701-2163     ISO Abbreviation:  J Obstet Gynaecol Can     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-12-23     Completed Date:  2011-02-03     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  101126664     Medline TA:  J Obstet Gynaecol Can     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  990-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biopsy
Endometrial Hyperplasia / epidemiology,  pathology,  ultrasonography*
Endometrial Neoplasms / pathology
Endometrium / pathology,  ultrasonography
Female
Humans
Polyps / pathology,  ultrasonography
Postmenopause*
Risk Factors
Tamoxifen / adverse effects
Uterine Hemorrhage / pathology
Chemical
Reg. No./Substance:
094ZI81Y45/Tamoxifen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The "Warfarin Window" in Pregnancy: The Importance of Half-life.
Next Document:  Influence of oligohydramnios on preterm premature rupture of the membranes at 30 to 36 weeks' gestat...